Company
IQVIA Holdings Inc.
Headquarters: Durham, NC, United States
Founded: 1982
Employees: 79,000
CEO: Mr. Ari Bousbib
Market Cap
$37.39 Billion
USD as of Jan. 1, 2025
IQVIA Holdings Inc. Categories
United States Healthcare Diagnostics & ResearchUnited States Healthcare United States Diagnostics & Research
Top Competitors by Market Capitalization
Industry: Diagnostics & Research
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $219.88 B |
| Danaher | $177.43 B |
| Siemens Healthineers AG | $59.19 B |
| Agilent Technologies, Inc. | $43.57 B |
| Lonza Group Ltd | $41.66 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Financials
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | $15.32 B |
| EBITDA | $3.40 B |
| Gross Profit TTM | $5.39 B |
| Profit Margin | 9.17% |
| Operating Margin | 14.84% |
| Quarterly Revenue Growth | 4.30% |
Stocks & Indices
IQVIA Holdings Inc. has the following listings and related stock indices.
Stock: NYSE: IQV wb_incandescent
Stock: BMV: IQV wb_incandescent
Stock: Bovespa: I1QV34 wb_incandescent
Stock: FSX: QTS wb_incandescent
Stock: XETR: QTS wb_incandescent
Product & Services
Support services for pharmaceutical, biotech and medical companies and individuals
Key People
Dennis Gillings (Founder) Ari Bousbib (Chairman & CEO)